GOLDMAN CAPITAL MANAGEMENT INC - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V105. A total of 1 filers reported holding BIOCEPT INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN CAPITAL MANAGEMENT INC ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2017$213,000
+21.0%
100,000
-55.6%
0.20%
+33.3%
Q4 2016$176,000225,0000.15%
Other shareholders
BIOCEPT INC shareholders Q2 2017
NameSharesValueWeighting ↓
Archon Capital Management LLC 586,300$1,495,0001.46%
GARRISON BRADFORD & ASSOCIATES INC 136,800$349,0000.34%
KENNEDY CAPITAL MANAGEMENT LLC 705,680$1,799,0000.03%
Sterneck Capital Management, LLC 19,750$50,0000.03%
Callan Capital, LLC 17,000$43,0000.01%
MOODY LYNN & LIEBERSON, LLC 15,000$38,0000.01%
HOWE & RUSLING INC 1,200$3,0000.00%
BLAIR WILLIAM & CO/IL 10,000$26,0000.00%
BlackRock Institutional Trust Company, N.A. 3,496$9,0000.00%
MSI Financial Services Inc 1,300$3,0000.00%
View complete list of BIOCEPT INC shareholders